US Patent

US9649296 — Heat sterilizeable, premixed, ready to use dexmedetomidine solution packaged in a flexible plastic container

Formulation · Assigned to Slypharma LLC · Expires 2036-04-20 · 10y remaining

Vulnerability score 25/100 Strong — defensible against typical IPR challenges

What this patent protects

This patent protects a premixed, ready-to-use dexmedetomidine solution packaged in a flexible plastic container for parenteral administration.

USPTO Abstract

The presently disclosed subject matter relates to pharmaceutical compositions comprising dexmedetomidine or a pharmaceutically acceptable salt thereof wherein the composition is formulated as a liquid for parenteral administration to a subject, and wherein the composition is disposed in a flexible plastic container as a ready to use premixed solution.

Drugs covered by this patent

chembl-chembl2106195 (DEXMEDETOMIDINE HYDROCHLORIDE)

Patent Metadata

Patent number: US9649296
Jurisdiction: US
Classification: Formulation
Expires: 2036-04-20
Drug substance claim: No
Drug product claim: Yes
Assignee: Slypharma LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.